Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment
Stopped Study withdrawn because of toxicity reported on the adult phase 1 trial.
Conditions
- Brain and Central Nervous System Tumors
- Leukemia
- Lymphoma
- Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
- DRUG: talotrexin
- PROCEDURE: chemotherapy
Sponsor
Children's Oncology Group
Collaborators